[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12826]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Cerilliant Corporation

    By Notice dated March 8, 2012, and published in the Federal 
Register on March 20, 2012, 77 FR 16261, Cerilliant Corporation, 811 
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application 
by letter to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-methyl-N-methylcathinone (1248)..........  I
1-Pentyl-3-(1-naphthoyl)indole (7118)......  I
1-Butyl-3-(1-naphthoyl) indole (7173)......  I
1-[2-(4-Morpholinyl)-ethyl{time} -3-(1-      I
 naphthoyl)indole (7200).
5-(1,1-Dimethylheptyl)-2-{(1R,3S)-3-         I
 hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2[(1R,3S)-3-           I
 hydroxycyclohexyl] phenol (7298).
3,4-methylenedioxypyrovalerone (7535)......  I
3,4-methylenedioxy-N-methylcathinone (7540)  I
Desomorphine (9055)........................  I
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Cerilliant Corporation to import the basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Cerilliant 
Corporation to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12826 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P